Monograph Details
|
|
Gastrointestinal Tract
> Colorectal disorders
|
|
PROCTOFOAM-HC |
| Manufacturer |
|
Schwarz Pharma, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Anesthetic + steroid. |
| Generic Name |
|
Pramoxine HCl 1%, hydrocortisone acetate 1%; aerosol foam. |
| Indications |
|
Steroid-responsive anogenital dermatoses. |
| Children |
|
Apply least amount compatible with therapeutic regimen. |
| Adults |
|
Apply 3–4 times daily. |
| Precautions |
|
Tuberculosis. Diverticulitis. Treat infection if present. Significant systemic absorption may occur. Discontinue if no improvement in 2–3 weeks. Children. Vaccinations. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Adrenal suppression, dermal and epidermal atrophy, poor wound healing, local irritation: folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, macerations, secondary infections, striae, miliaria. |
| How Supplied |
|
Aerosol—10g (w. applicator) |
|
|
|
|
